What is the role of extracorporeal magnetic resonance therapy in urinary incontinence treatment?

Updated: Mar 19, 2019
  • Author: Sandip P Vasavada, MD; Chief Editor: Edward David Kim, MD, FACS  more...
  • Print
Answer

Extracorporeal magnetic resonance therapy has been introduced as a therapy for stress incontinence. The NeoControl unit (Neotonus, Marietta, Ga.) was approved by the Food and Drug Administration (FDA) for this purpose in 2000. Resonating magnetic flux within a magnetic field induces electrical depolarization of targeted nerves and muscles. No probes are required. The patient simply sits on a chair containing the magnetic device.

A small study achieved an improvement rate of 77% after 8 weeks of therapy, with 56% of patients being completely dry. However, a 3-year follow-up study found that the benefits tend to be temporary: at 6 months, the recurrence rate was 53%. [92]


Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!